Glioma-produced Extracellular Matrix Influences Brain Tumor Tropism of Human Neural Stem Cells

Overview

Journal J Neurooncol

Publisher Springer

Date 2006 Apr 7

PMID 16598423

Citations 33

Authors

Mateo Ziu

Nils Ole Schmidt

Theresa G Cargioli

Karen S Aboody

Peter McL Black

Rona S Carroll

Affiliations

Soon will be listed here.

Abstract

A major obstacle in the treatment of gliomas is the invasive capacity of the tumor cells. Previous studies have demonstrated the capability of neural stem cells (NSCs) to target these disseminated tumor cells and to serve as therapeutic delivery vehicles. Less is known about the factors involved in brain tumor tropism of NSCs and their interactions within the tumor environment. As gliomas progress and invade, an extensive modulation of the extracellular matrix (ECM) occurs. Tumor-ECM derived from six glioblastoma cell lines, ECM produced by normal human astrocytes and purified ECM compounds known to be upregulated in the glioma environment were analyzed for their effects on NSCs motility in vitro. We found that tumor-produced ECM was highly permissive for NSC migration. Laminin was the most permissive substrate for human NSC migration, and tenascin-C the strongest inducer of a directed human NSC migration (haptotaxis). A positive correlation between the degree of adhesion and migration of NSCs on different ECM compounds exists, as for glioma cells. Our in vitro data suggest that the ECM of malignant gliomas is a modulator of NSC migration. ECM proteins preferentially expressed in areas of glioma cell invasion may provide a permissive environment for NSC tropism to disseminated tumor cells.

Citing Articles

IDH1 R132H and TP53 R248Q Mutations Modulate Glioma Cell Migration and Adhesion on Different ECM Components.

Shmelev M, Pilnik A, Shved N, Penkova A, Gulaia V, Kumeiko V Int J Mol Sci. 2024; 25(22).

PMID: 39596246 PMC: 11594609. DOI: 10.3390/ijms252212178.

Mesenchymal stem cells: a trojan horse to treat glioblastoma.

Chartouni A, Mouawad A, Boutros M, Attieh F, Medawar N, Kourie H Invest New Drugs. 2023; 41(2):240-250.

PMID: 37017885 DOI: 10.1007/s10637-023-01352-9.

To Explore the Stem Cells Homing to GBM: The Rise to the Occasion.

Tsibulnikov S, Drefs N, Timashev P, Ulasov I Biomedicines. 2022; 10(5).

PMID: 35625723 PMC: 9138893. DOI: 10.3390/biomedicines10050986.

Progress in mimicking brain microenvironments to understand and treat neurological disorders.

Ngo M, Harley B APL Bioeng. 2021; 5(2):020902.

PMID: 33869984 PMC: 8034983. DOI: 10.1063/5.0043338.

Allogeneic human neural stem cells for improved therapeutic delivery to peritoneal ovarian cancer.

Mooney R, Abidi W, Batalla-Covello J, Ngai H, Hyde C, Machado D Stem Cell Res Ther. 2021; 12(1):205.

PMID: 33761999 PMC: 7992793. DOI: 10.1186/s13287-021-02226-8.

References

Louissaint Jr A, Rao S, Leventhal C, Goldman S . Coordinated interaction of neurogenesis and angiogenesis in the adult songbird brain. Neuron. 2002; 34(6):945-60. DOI: 10.1016/s0896-6273(02)00722-5. View

Brown A, Yang W, Schmidt N, Carroll R, Leishear K, Rainov N . Intravascular delivery of neural stem cell lines to target intracranial and extracranial tumors of neural and non-neural origin. Hum Gene Ther. 2003; 14(18):1777-85. DOI: 10.1089/104303403322611782. View

Kearns S, Laywell E, Kukekov V, Steindler D . Extracellular matrix effects on neurosphere cell motility. Exp Neurol. 2003; 182(1):240-4. DOI: 10.1016/s0014-4886(03)00124-9. View

Palmer T, Willhoite A, Gage F . Vascular niche for adult hippocampal neurogenesis. J Comp Neurol. 2000; 425(4):479-94. DOI: 10.1002/1096-9861(20001002)425:4<479::aid-cne2>3.0.co;2-3. View

Garcion E, Halilagic A, Faissner A, ffrench-Constant C . Generation of an environmental niche for neural stem cell development by the extracellular matrix molecule tenascin C. Development. 2004; 131(14):3423-32. DOI: 10.1242/dev.01202. View

Meng X, Shen J, Ohashi T, Maeda H, Kim S, Eto Y . Brain transplantation of genetically engineered human neural stem cells globally corrects brain lesions in the mucopolysaccharidosis type VII mouse. J Neurosci Res. 2003; 74(2):266-77. DOI: 10.1002/jnr.10764. View

Schmidt N, Przylecki W, Yang W, Ziu M, Teng Y, Kim S . Brain tumor tropism of transplanted human neural stem cells is induced by vascular endothelial growth factor. Neoplasia. 2005; 7(6):623-9. PMC: 1501284. DOI: 10.1593/neo.04781. View

Ohnishi T, Hiraga S, Izumoto S, Matsumura H, Kanemura Y, Arita N . Role of fibronectin-stimulated tumor cell migration in glioma invasion in vivo: clinical significance of fibronectin and fibronectin receptor expressed in human glioma tissues. Clin Exp Metastasis. 1999; 16(8):729-41. DOI: 10.1023/a:1006532812408. View

Kueng W, Silber E, Eppenberger U . Quantification of cells cultured on 96-well plates. Anal Biochem. 1989; 182(1):16-9. DOI: 10.1016/0003-2697(89)90710-0. View

10.

Mahesparan R, Read T, Lund-Johansen M, Skaftnesmo K, Bjerkvig R, Engebraaten O . Expression of extracellular matrix components in a highly infiltrative in vivo glioma model. Acta Neuropathol. 2002; 105(1):49-57. DOI: 10.1007/s00401-002-0610-0. View

11.

Thompson J, George E, Poquette C, Cheshire P, Richmond L, de Graaf S . Synergy of topotecan in combination with vincristine for treatment of pediatric solid tumor xenografts. Clin Cancer Res. 1999; 5(11):3617-31. View

12.

Giese A, Rief M, Loo M, Berens M . Determinants of human astrocytoma migration. Cancer Res. 1994; 54(14):3897-904. View

13.

Aboody K, Brown A, Rainov N, Bower K, Liu S, Yang W . Neural stem cells display extensive tropism for pathology in adult brain: evidence from intracranial gliomas. Proc Natl Acad Sci U S A. 2000; 97(23):12846-51. PMC: 18852. DOI: 10.1073/pnas.97.23.12846. View

14.

Giese A, Westphal M . Glioma invasion in the central nervous system. Neurosurgery. 1996; 39(2):235-50; discussion 250-2. DOI: 10.1097/00006123-199608000-00001. View

15.

Bosman F, Stamenkovic I . Functional structure and composition of the extracellular matrix. J Pathol. 2003; 200(4):423-8. DOI: 10.1002/path.1437. View

16.

Bouterfa H, Darlapp A, Klein E, Pietsch T, Roosen K, Tonn J . Expression of different extracellular matrix components in human brain tumor and melanoma cells in respect to variant culture conditions. J Neurooncol. 1999; 44(1):23-33. DOI: 10.1023/a:1006331416283. View

17.

George E, Rayburn H, Hynes R . Defects in mesoderm, neural tube and vascular development in mouse embryos lacking fibronectin. Development. 1993; 119(4):1079-91. DOI: 10.1242/dev.119.4.1079. View

18.

de Wever O, Mareel M . Role of tissue stroma in cancer cell invasion. J Pathol. 2003; 200(4):429-47. DOI: 10.1002/path.1398. View

19.

Giese A, Rief M, Tran N, Berens M . Specific attachment and migration of human astrocytoma cells on human but not murine laminin. Glia. 1995; 13(1):64-74. DOI: 10.1002/glia.440130108. View

20.

Friedlander D, Zagzag D, Shiff B, Cohen H, Allen J, Kelly P . Migration of brain tumor cells on extracellular matrix proteins in vitro correlates with tumor type and grade and involves alphaV and beta1 integrins. Cancer Res. 1996; 56(8):1939-47. View